A Study of Sepiapterin in Participants With Phenylketonuria (PKU) | MicrobiomeTrials← Back to trialsNCT06302348
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-03-04Est. Completion: 2031-02-28
Enrollment target: 56 participants Locations- Indiana University School of Medicine, Indianapolis, Indiana, United States
- Women and Children Hospital, North Adelaide, Australia
- The Royal Children's Hospital, Parkville, Australia
- Centre Hospitalier Universitaire (CHU) de Lille - Hôpital Jeanne de Flandre, Lille, France
- Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Necker-Enfants Malades, Paris, France
- Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Clocheville, Tours, France
- Children's Health Ireland (CHI), Dublin, Ireland
- Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin, Poland
- Instytut Matki i Dziecka, Warsaw, Poland
- Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom
Other microbiome trials you might be interested in
Phenylketonuria
Phenylketonuria (PKU) is an inherited disorder of phenylalanine (Phe) metabolism. The mainstay of treatment is a Phe-res…
Birmingham, United KingdomEst. completion Dec 2026
Phenylketonuria (PKU)
This is a Phase 3 open-label randomized controlled study enrolling approximately 54 adolescents with PKU. The study is d…
Phoenix, United StatesEst. completion Jan 14, 2025